FDA Approved: TELMISARTAN — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's original submission for Telmisartan, a generic angiotensin II receptor blocker indicated for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

ORIG AP for TELMISARTAN (TELMISARTAN)